Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
2.
Ned Tijdschr Geneeskd ; 161: D1356, 2017.
Artigo em Holandês | MEDLINE | ID: mdl-28659207

RESUMO

BACKGROUND: The use of 4-fluoroamphetamine (4-FA) has shown a marked increase, especially because users perceive its effects to be relatively mild. 4-FA is also known as ecstacy-light, but is probably not as light as its name suggests. From April 2017 its use has therefore been forbidden in the Netherlands. CASE DESCRIPTION: In a short time, we saw three patients at our emergency department who had signs of a severe intoxication with 4-FA. A 21-year-old male developed a tonic-clonic seizure, bruxism, mydriasis, and rhabdomyolysis. A 19-year-old female was confused and was longing for death. A 22-year-old male needed to be admitted to intensive care to be intubated, sedated and cooled due to tachycardia, hypertension and hyperthermia. CONCLUSION: Because of its relatively mild effects, 4-FA is gaining in popularity in the Netherlands. However, the use of this designer drug can lead to severe problems such as severe confusion, hyperthermia and tonic-clonic seizures.


Assuntos
Transtornos Relacionados ao Uso de Anfetaminas/epidemiologia , Anfetaminas/efeitos adversos , Estimulantes do Sistema Nervoso Central/efeitos adversos , Adulto , Transtornos Relacionados ao Uso de Anfetaminas/prevenção & controle , Feminino , Humanos , Masculino , Países Baixos , Convulsões/induzido quimicamente , Adulto Jovem
3.
Neth J Med ; 75(1): 45, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-28124676
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...